TriSalus Life Sciences (TLSI) Other Working Capital Changes (2021)

TriSalus Life Sciences' Other Working Capital Changes history runs 1 years deep, the most recent figure standing at -$103714.0 for Q2 2021.

• On a quarterly basis, Other Working Capital Changes rose 44.64% year-over-year to -$31000.0 in Q1 2026; TTM through Mar 2026 was -$109000.0, a 56.22% increase from a year earlier, with the FY2025 full-year figure at -$134000.0, up 51.8% from the prior year.
• Other Working Capital Changes slipped to -$31000.0 in Q1 2026 per TLSI's latest filing, from -$27000.0 in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $131000.0 in Q2 2023 and bottomed at -$261000.0 in Q3 2023.
• The 5-year median for Other Working Capital Changes is -$62000.0 (2024), against an average of -$60642.9.
• Biggest YoY gain for Other Working Capital Changes was 73.95% in 2024; the steepest drop was 164.89% in 2024.
• Year by year, Other Working Capital Changes stood at -$125000.0 in 2022, then surged by 36.8% to -$79000.0 in 2023, then soared by 49.37% to -$40000.0 in 2024, then soared by 32.5% to -$27000.0 in 2025, then declined by 14.81% to -$31000.0 in 2026.
• Per Business Quant, the three latest TLSI Other Working Capital Changes figures stand at -$31000.0 (Q1 2026), -$27000.0 (Q4 2025), and -$26000.0 (Q3 2025).